Plasma transforming growth factor-β1 reflects disease status in patients with lung cancer after radiotherapy: a possible tumor marker
- 31 December 1996
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 16 (1) , 47-59
- https://doi.org/10.1016/s0169-5002(96)00611-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosityNature Genetics, 1995
- Elevated Plasma Transforming Growth Factor-β1 Levels in Breast Cancer Patients Decrease After Surgical Removal of the TumorAnnals of Surgery, 1995
- Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite InstabilityScience, 1995
- Elevated plasma levels of TGF-β1 in patients with invasive prostate cancerNature Medicine, 1995
- The relationship between the immunodetection of transforming growth factor-β in lung adenocarcinoma and longer survival ratesSurgical Oncology, 1995
- Growth factor balance and tumor progressionCurrent Opinion in Oncology, 1994
- Expression of c-erbB2, TGF-β1 and pS2 genes in primary human breast cancersEuropean Journal Of Cancer, 1992
- Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia.The Journal of Experimental Medicine, 1990
- Immunocytochemically Detectable TGF-β Associated with Malignancy in Thyroid Epithelial NeoplasiaGrowth Factors, 1990
- Absence of TGF-β Receptors and Growth Inhibitory Responses in Retinoblastoma CellsScience, 1988